NEA Management Company, LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 36 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,602,425
-40.5%
2,294,095
-23.4%
0.11%
-26.5%
Q4 2022$2,693,662
-85.7%
2,992,958
-4.8%
0.15%
-84.0%
Q3 2022$18,858,000
+44.9%
3,142,9580.0%0.94%
+40.9%
Q2 2022$13,012,000
+9.0%
3,142,9580.0%0.67%
+93.6%
Q1 2022$11,943,000
-15.6%
3,142,9580.0%0.34%
+20.6%
Q4 2021$14,143,000
-3.4%
3,142,9580.0%0.29%
+64.4%
Q3 2021$14,646,000
-33.9%
3,142,9580.0%0.17%
-39.8%
Q2 2021$22,158,000
+25.1%
3,142,958
+4.8%
0.29%
-27.4%
Q1 2021$17,716,0002,997,6820.40%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,431,705$14,371,0005.72%
Ghost Tree Capital, LLC 904,225$5,136,0001.21%
RA Capital Management 5,914,252$34,953,0000.53%
NEA Management Company, LLC 2,997,682$17,716,0000.40%
Vivo Capital, LLC 1,232,394$7,283,0000.26%
Monashee Investment Management LLC 176,057$1,040,0000.16%
Ikarian Capital, LLC 676,294$3,997,0000.14%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$11,146,0000.13%
SAMLYN CAPITAL, LLC 1,232,394$7,283,0000.10%
Maven Securities LTD 173,029$1,026,0000.05%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders